News about Industrial talks

Alembic Pharma Names Ramesh Juneja as EVP, Human Health

Alembic Pharmaceuticals has appointed Ramesh Juneja as Executive Vice President–Human Health for its India business. Bringing leadership experience from Sun Pharma, Cipla and Reliance Retail, Juneja will spearhead sales and marketing initiatives to drive growth in Alembic’s domestic pharmaceutical business.

Industrial talks | 02/06/2026 | By News Bureau |  138

EMA Recommends XFG-Targeted COVID-19 Vaccines for 2026-2027 Immunisation Campaign

The European Medicines Agency’s Emergency Task Force has recommended updating COVID-19 vaccines to target the XFG variant for the 2026–2027 vaccination season, aiming to enhance protection against circulating SARS-CoV-2 strains.

Industrial talks | 01/06/2026 | By News Bureau |  201

Alkem Reports Record FY26 EBITDA as Revenue Grows 13.5%; Q4 Profit Before Tax Rises 40.7 Percent

Alkem Laboratories posted its highest-ever EBITDA in FY26, driven by strong growth in domestic and international businesses, improved operating leverage, and disciplined cost management. The company also reported robust fourth-quarter performance, with revenue rising 14.6 percent and PBT before exceptional items increasing 40.7 percent YoY.

Industrial talks | 29/05/2026 | By News Bureau |  187

Consultative Meeting on WHO-ICHI Framework and Traditional Medicine Health Codes Concludes

India’s Ministry of Ayush held a two-day consultative meeting on the World Health Organization (WHO)-ICHI framework and National Health Intervention Codes to advance standardised coding systems for Ayurveda, Siddha, and Unani practices under global traditional medicine classification initiatives.

Industrial talks | 28/05/2026 | By News Bureau |  103

PCIM&H Concludes 5-Day Training Program for ASU&H Drug Regulators and Stakeholders

The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) concluded a 5-day capacity building program for ASU&H drug regulators and stakeholders, aimed at strengthening regulatory knowledge, quality standards, and technical competencies across ASU&H sector.

Industrial talks | 25/05/2026 | By News Bureau |  145

Mabylon Advances Peanut Allergy Drug MY006 After Positive Early Clinical Data

Mabylon AG has reported positive preliminary Phase Ia results for MY006, its antibody-based peanut allergy treatment candidate, while also advancing a second allergy programme targeting tree pollen allergens.

Industrial talks | 20/05/2026 | By News Bureau |  216

IPC Hosts Scientific Conclave and Interactive Session on Indian Pharmacopoeia 2026 at NIPER Hyderabad

Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.

Industrial talks | 16/05/2026 | By News Bureau |  147

Avid Bioservices Names Kerri McCullough Wood Chief Commercial Officer

Avid Bioservices appoints Kerri McCullough Wood as Chief Commercial Officer (CCO) to lead global commercial strategy and accelerate growth across early- and late-phase biologics programs.

Industrial talks | 12/05/2026 | By News Bureau |  128

NIPER Raebareli Signs CDA and Tech Transfer Pact with Lofty Laboratories

NIPER Raebareli signs CDA and technology transfer agreement with Lofty Laboratories to advance indigenous technology commercialisation in biotechnology sector.

Industrial talks | 11/05/2026 | By News Bureau |  112

Viatris Appoints Paul Campbell as Interim Chief Financial Officer

Viatris announces Chief Financial Officer (CFO) transition as Theodora “Doretta” Mistras departs and Paul Campbell is named interim CFO, ensuring leadership continuity.

Industrial talks | 05/05/2026 | By News Bureau |  165